Раскройте тайны своей усталости: 12 шагов для подзарядки энергией, исцеления тела и трансформации

15. Rowe, P.C., et al. (2017), ‘Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer’: www.ncbi.nlm.nih.gov/pubmed/28674681.

16. McEvedy, C.P. and Beard, A.W. (1970), ‘Concept of benign myalgic encephalomyelitis’: www.ncbi.nlm.nih.gov/pubmed/5411596.

17. McManimen, S., et al. (2019), ‘Dismissing chronic illness: A qualitative analysis of negative health care experiences’: www.ncbi.nlm.nih.gov/pubmed/30829147.

18. Friedman, K.J. (2019), ‘Advances in ME/CFS: Past, Present, and Future’: www.ncbi.nlm.nih.gov/pubmed/31058116.

19. Centers for Disease Control and Prevention (2020), ‘Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)’: www.cdc.gov/me-cfs/index.html.

20. Raine, R., et al. (2004), ‘General practitioners’ perceptions of chronic fatigue syndrome and beliefs about its management, compared with irritable bowel syndrome: qualitative study’: www.ncbi.nlm.nih.gov/pmc/articles/PMC420289/.

21. Lian, O.S. and Robson, C. (2017), ‘“It’s incredible how much I’ve had to fight”’; negotiating medical uncertainty in clinical encounters’: www.ncbi.nlm.nih.gov/pubmed/29063801.

22. Collin, S.M. and Crawley, E. (2017), ‘Specialist treatment of chronic fatigue syndrome/ME: a cohort study among adult patients in England’: www.ncbi.nlm.nih.gov/pubmed/28709432.

23. Maizes, V., etal. (2009), ‘Integrative Medicine and Patient-Centered Care’: www.sciencedirect.com/science/article/abs/pii/S1550830709002341?via%3Dihub.

24. Ali, A. and Katz, D.L. (2015), ‘Disease Prevention and Health Promotion: How Integrative Medicine Fits’: www.ncbi.nlm.nih.gov/pubmed/26477898.

25. Bland, J. (2015), ‘Functional Medicine: An Operating System for Integrative Medicine’: http://www.ncbi.nlm.nih.gov/pubmed/26770161.

26. National Institute of Clinical Excellence (NICE) (2007), ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) in adults and children’: http://guidance.nice.org.uk/CG53/Guidance/pdf/English.

27. Baker, R. and Shaw, E.J. (2007), ‘Guidelines: Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): Summary of NICE guidance’, British Medical Journal, 335(7617): 446–8.

28. Jones, J.F. et al. (2009), ‘An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome’: https://pubmed.ncbi.nlm.nih.gov/19818157/.

29. Fukuda, K. et al. (1994), ‘The chronic fatigue syndrome: a comprehensive approach to its definition and study’: www.ncbi.nlm.nih.gov/pubmed/7978722.

30. Brurberg, K.G. et al. (2014), ‘Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review’: www.ncbi.nlm.nih.gov/pubmed/24508851.

31. Brimmer, D.J. et al. (2013), ‘A pilot registry of unexplained fatiguing illnesses and chronic fatigue syndrome’: www.ncbi.nlm.nih.gov/pubmed/23915640.

32. Bansal, A.S. (2016), ‘Investigating unexplained fatigue in general practice with a particular focus on CFS/ME’: www.ncbi.nlm.nih.gov/pubmed/27436349.

33. Strand, E.B. et al. (2019), ‘Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union’: www.ncbi.nlm.nih.gov/pubmed/31805176.

34. Cohen, H. (2017), ‘Controversies and challenges in fibromyalgia: a review and a proposal’: www.ncbi.nlm.nih.gov/pubmed/28458723.

35. Arnold, L.M. et al. (2016), ‘Fibromyalgia and Chronic Pain Syndromes: A White Paper Detailing Current Challenges in the Field’: www.ncbi.nlm.nih.gov/pubmed/ 27022674.

36. Garcia-Monco, J.C. and Benach, J.L. (2019), ‘Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections’: www.ncbi.nlm.nih.gov/pubmed/30536421.

37. Jaulhac, B., et al. (2019), ‘Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis’: www.sciencedirect.com/science/article/pii/S0399077X19301313?via%3Dihub.

38. Rauer, S., et al. (2018), ‘Lyme Neuroborreliosis’: www.ncbi.nlm.nih.gov/pubmed/ 30573008.

39. Baker, P.J. (2020), ‘A Review of Antibiotic-Tolerant Persisters and Their Relevance to Post-treatment Lyme Disease Symptoms’: www.ncbi.nlm.nih.gov/pubmed/ 31926865.

Глава 3. Как ваше тело создает энергию

40. Morris, G. and Maes, M. (2014), ‘Mitochondrial dysfunctions in Myalgic Encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways’, Metabolic Brain Disease, 29(1): 19–36.

41. Zare˛bska, A.E., et al. (2018), ‘Plasma Nucleotide Dynamics during Exercise and Recovery in Highly Trained Athletes and Recreationally Active Individuals’: www.hindawi.com/journals/bmri/2018/4081802.